Coty Ho
Medical Oncology · la Quinta, CANPI 1497808950
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 58 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 24 manufacturers, the largest accounting for just 13.7% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $972 and has fallen 94.8% since, to $50 in 2025. That places this record below the midpoint for medical oncology clinicians in CA, where the typical reported total is $4,042.
Across 58 payments — averaging $19.26 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Merck$153
- Novartis$134
- AstraZeneca$78
- AbbVie$73
- E.r. Squibb & Sons, L.L.C.$73
- Mylan Institutional Inc.$71
- plus $535 from 18 others
Across 32 payments — averaging $3483.04 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Amgen$39K
- Roche Products Limited$23K
- Merck$19K
- AVEO Pharmaceuticals, Inc.$17K
- E.r. Squibb & Sons, L.L.C.$13K
What the payments were for
- Food & beverage$1,117100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Merck | 9 | $153 |
| Novartis | 7 | $134 |
| AstraZeneca | 4 | $78 |
| AbbVie | 4 | $73 |
| E.r. Squibb & Sons, L.L.C. | 4 | $73 |
| Mylan Institutional Inc. | 3 | $71 |
| Amgen | 3 | $67 |
| Sun Pharmaceutical Industries Inc. | 4 | $67 |
| Janssen Scientific Affairs, LLC | 2 | $55 |
| Sanofi | 2 | $42 |
| Dendreon Pharmaceuticals LLC | 1 | $35 |
| Array Biopharma Inc | 2 | $27 |
| Boehringer Ingelheim | 2 | $25 |
| Daiichi Sankyo Inc. | 1 | $25 |
| Tolmar Pharmaceuticals, Inc. | 1 | $25 |
| Verastem, Inc. | 1 | $24 |
| Lilly USA, LLC | 1 | $23 |
| Exelixis Inc. | 1 | $22 |
| Teva Pharmaceuticals USA, Inc. | 1 | $21 |
| Pfizer | 1 | $16 |
| Monteris Medical Corporation | 1 | $16 |
| Foundation Medicine, Inc. | 1 | $16 |
| Puma Biotechnology, Inc. | 1 | $15 |
| Bayer | 1 | $14 |
How this compares
$1,117 in reported general payments places this provider in the 30th percentile of 379 medical oncology providers in California.
Other medical oncology in la Quinta
- Stephen SherwinSan Francisco$6.9M
- Noam DrazinBeverly Hills$1.4M
- Farshid DayyaniOrange$1.2M
- April TeitelbaumSan Diego$1.1M
- Przemyslaw TwardowskiSanta Monica$995K
- Ann LowePalo Alto$923K
- Marin XavierSan Diego$919K
- Munveer Bhangoola Jolla$804K
- Stephen LiuLos Angeles$750K
- Jacek PinskiLos Angeles$672K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.